Corrigendum to: Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma (Clinical & Translational Immunology, (2021), 10, 5, 10.1002/cti2.1283)

Abstract

Clinical & Translational Immunology 2021; 10: e1317. Correction to: Clin Trans Immunol 2021; 10: e1283. https://doi.org/10.1002/cti2.1283. Published online 9 May 2021 Figure 5 originally published in this article was incorrect, as it contained a duplicated mouse image. The corrected Figure 5 and its caption appear below. The authors apologise for this error. (Figure presented.) GCT02 CAR T cells effectively induce regression of intracranial tumors. (a) Schematic of the experimental protocol to evaluate the in vivo function of CAR T cells against EGFRvIII-expressing intracranial tumors. Mice were intracranially injected with U87-EGFRvIII GFP-Luc tumor cells and 7 days later were imaged using ..